274 related articles for article (PubMed ID: 27703107)
1. [The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects].
Tarutani A; Hisanaga SI; Hasegawa M
Brain Nerve; 2016 Oct; 68(10):1197-1204. PubMed ID: 27703107
[TBL] [Abstract][Full Text] [Related]
2. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders.
Hasegawa M; Nonaka T; Masuda-Suzukake M
Pharmacol Ther; 2017 Apr; 172():22-33. PubMed ID: 27916654
[TBL] [Abstract][Full Text] [Related]
3. Prion-like properties of assembled TDP-43.
Nonaka T; Hasegawa M
Curr Opin Neurobiol; 2020 Apr; 61():23-28. PubMed ID: 31862626
[TBL] [Abstract][Full Text] [Related]
4. Prion-like propagation of α-synuclein in neurodegenerative diseases.
Tarutani A; Hasegawa M
Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
[TBL] [Abstract][Full Text] [Related]
5. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
6. Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases.
Victoria GS; Zurzolo C
Virus Res; 2015 Sep; 207():146-54. PubMed ID: 25645281
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.
Tarutani A; Adachi T; Akatsu H; Hashizume Y; Hasegawa K; Saito Y; Robinson AC; Mann DMA; Yoshida M; Murayama S; Hasegawa M
Acta Neuropathol; 2022 Jun; 143(6):613-640. PubMed ID: 35513543
[TBL] [Abstract][Full Text] [Related]
8. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
Goedert M; Masuda-Suzukake M; Falcon B
Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
[TBL] [Abstract][Full Text] [Related]
9. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
10. Propagation of prions causing synucleinopathies in cultured cells.
Woerman AL; Stöhr J; Aoyagi A; Rampersaud R; Krejciova Z; Watts JC; Ohyama T; Patel S; Widjaja K; Oehler A; Sanders DW; Diamond MI; Seeley WW; Middleton LT; Gentleman SM; Mordes DA; Südhof TC; Giles K; Prusiner SB
Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4949-58. PubMed ID: 26286986
[TBL] [Abstract][Full Text] [Related]
11. Experimental models of prion-like protein propagation.
Hasegawa M
Neuropathology; 2020 Oct; 40(5):460-466. PubMed ID: 32478452
[TBL] [Abstract][Full Text] [Related]
12. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
13. The role of crowded physiological environments in prion and prion-like protein aggregation.
Ma Q; Hu JY; Chen J; Liang Y
Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393
[TBL] [Abstract][Full Text] [Related]
14. TDP-43 Prions.
Nonaka T; Hasegawa M
Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28108532
[TBL] [Abstract][Full Text] [Related]
15. [Are neurodegenerative diseases "protein cancers"?].
Hasegawa M
Brain Nerve; 2012 Jun; 64(6):675-9. PubMed ID: 22647475
[TBL] [Abstract][Full Text] [Related]
16. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
17. Role of cellular prion protein in interneuronal amyloid transmission.
Del Río JA; Ferrer I; Gavín R
Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
[TBL] [Abstract][Full Text] [Related]
18. Prion-like mechanisms in neurodegenerative diseases.
Frost B; Diamond MI
Nat Rev Neurosci; 2010 Mar; 11(3):155-9. PubMed ID: 20029438
[TBL] [Abstract][Full Text] [Related]
19. Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration.
Scialò C; De Cecco E; Manganotti P; Legname G
Viruses; 2019 Mar; 11(3):. PubMed ID: 30875755
[TBL] [Abstract][Full Text] [Related]
20. A critical review of the prion hypothesis of human synucleinopathies.
Tamgüney G; Korczyn AD
Cell Tissue Res; 2018 Jul; 373(1):213-220. PubMed ID: 29116402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
